Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
Management of superficial basal cell carcinoma: focus on imiquimod
Clinical, Cosmetic and Investigational Dermatology, 06/12/09
Raasch B - Imiquimod 5% cream has been shown to stimulate the innate and cell mediated immune system. The short-term success of imiquimod 5% cream in randomized controlled trials comparing different treatment regimes and dosing as a treatment for small superficial basal cell carcinoma (BCC) not on the face or neck is in the range of 82% for 5 times per week application. A high proportion of participants with good response rates to topical treatment (58%–92%) experience local side effects such as itching and burning, less commonly erosion and ulceration, but the proportion of participants ceasing treatment has not been high.
Related Articles
Cytokeratin expression patterns in multiple infundibulocystic basal cell carcinoma
Journal of Cutaneous Pathology, 10/28/09
Relevance Score: 82%
Big Bad BCCs: craniofacial resection and reconstruction for atypical basal cell carcinoma
Journal of Plastic, Reconstructive & Aesthetic Surgery, 11/03/09
Relevance Score: 81%
Basal Cell Carcinoma of the Nipple-Areola Complex
Dermatologic Surgery, 11/17/09
Relevance Score: 80%
Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies
International Journal of Dermatology, 11/12/09
Relevance Score: 80%
Multidrug Resistance in a Urothelial Cancer Cell Line After 1-Hour Mitomycin C Exposure
The Journal of Urology, 10/29/09
Relevance Score: 80%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Partially Hydrolyzed 100% Whey Protein Infant Formula and Reduced Risk of Atopic Dermatitis: A Meta-analysis
Journal of Pediatric Gastroenterology and Nutrition, 03/15/10
Topical 0.03% atropine vs. 15% aluminum chloride in treating multiple eccrine hidrocystomas: A randomized single blind controlled study
Indian Journal of Dermatology, 03/15/10
Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study
Annals of Oncology, 03/15/10
Today in Dermatologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Wide local excision could be considered as the initial treatment of primary anorectal malignant melanoma
Chinese Medical Journal, 03/15/10
Kaposi’s Sarcoma after Long-Acting Steroids: Time until Remission and Drug Washout
Dermatology, 03/15/10
Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study
Annals of Oncology, 03/15/10
Today in Dermatopathology...keeping you current
Receive free subspecialty "5-minute updates" via email
Cutaneous Lupus and the Cutaneous Lupus Erythematosus Disease Area and Severity Index Instrument
Rheumatic Disease Clinics of North America, 03/15/10
Regional nerve blockade prior to direct injection to achieve anaesthesia of the nasal ala
British Journal of Dermatology, 03/15/10
Topical 0.03% atropine vs. 15% aluminum chloride in treating multiple eccrine hidrocystomas: A randomized single blind controlled study
Indian Journal of Dermatology, 03/15/10
Article Search
Sponsor
Sponsor


See Latest Articles


